JF
PRAX icon

Jump Financial’s Praxis Precision Medicines PRAX Stock Holding History

Jump Financial’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,188
Closed -$861K – 1926
2024
Q4 		$861K Buy
+11,188
New +$810K 0.02% 817
2024
Q3 		– Sell
-14,321
Closed -$592K – 2024
2024
Q2 		$592K Buy
14,321
+10,872
+315% +$514K 0.01% 1066
2024
Q1 		$210K Buy
+3,449
New +$155K 0.01% 1657
2023
Q4 		– Sell
-2,177
Closed -$55.8K – 2144
2023
Q3 		$55.8K Buy
+2,177
New +$41.2K ﹤0.01% 1740
2022
Q4 		– Sell
-3,487
Closed -$119K – 1941
2022
Q3 		$119K Buy
3,487
+627
+22% +$31.2K ﹤0.01% 1428
2022
Q2 		$105K Buy
2,860
+1,967
+220% +$210K ﹤0.01% 1439
2022
Q1 		$137K Buy
+893
New +$183K 0.01% 1376

Other funds holding PRAX

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jump Financial's PRAX Position: Q1 2025 in Review

Jump Financial sold out of Praxis Precision Medicines (PRAX) in Q1 2025, closing a stake of 11,188 shares — an estimated $861K sold.

Jump Financial first reported a position in PRAX in Q1 2022 and held it in 7 quarters. The position peaked at $861K in Q4 2024. 150 funds tracked by Wall St. Rank hold PRAX as of Q1 2025.

  • Jump Financial reported no remaining Praxis Precision Medicines position as of Q1 2025 after selling out during the quarter.
  • Jump Financial sold 11,188 Praxis Precision Medicines shares in Q1 2025, an estimated $861K.
  • Jump Financial first reported a position in Praxis Precision Medicines in Q1 2022 and held it in 7 quarters.
  • Jump Financial's Praxis Precision Medicines position peaked at $861K in Q4 2024.
  • 150 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2025.

Based on Jump Financial's 13F filing for Q1 2025, filed 14 May 2025.